Literature DB >> 10364337

Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.

R Fearns1, P L Collins.   

Abstract

M2-1 protein of human respiratory syncytial virus (RSV) is a transcription antitermination factor that is important for the efficient synthesis of full-length mRNAs as well as for the synthesis of polycistronic readthrough mRNAs, which are characteristic of nonsegmented negative-strand RNA viruses. The contributions of these effects to RSV sequential transcription were investigated with minigenomes which contained one to five genes which were either foreign marker genes or authentic RSV genes. When evaluated on a promoter-proximal gene, the effect of M2-1 on the synthesis of full-length mRNA was much greater for a long (1,212- or 1,780-nucleotide) gene (up to a 615-fold increase) than for a short (274-nucleotide) gene (less than a 2-fold increase). This was independent of whether the gene contained non-RSV or RSV-specific sequence. Once the polymerase had terminated prematurely, it was unable to reinitiate at a downstream gene. These studies also confirmed that M2-1 enhances the synthesis of polycistronic mRNAs and that the magnitude of this effect varied greatly among different naturally occurring gene junctions. The synthesis of polycistronic mRNAs, which presumably involves antitermination at the gene-end signal, required a higher level of M2-1 than did the synthesis of the corresponding monocistronic mRNAs. M2-1 did not have a comparable antitermination effect at the junction between the leader region and the first gene. In a minigenome containing the NS1 and NS2 genes in their authentic sequence context, synthesis of full-length NS1 and NS2 mRNAs in the absence of M2-1 was remarkably high (36 and 57%, respectively, of the maximum levels observed in the presence of M2-1). In contrast, synthesis of mRNA from additional downstream genes was highly dependent on M2-1. Thus, RSV has the potential for two transcription programs: one in the absence of M2-1, in which only the NS1 and NS2 genes are transcribed, and one in the presence of M2-1, in which sequential transcription of the complete genome occurs. The dependence on M2-1 for transcription was greater for a gene in the fifth position from the promoter than for one in the third position. This indicates that under conditions where M2-1 is limiting, its concentration affects the gradient of transcription. Although M2-1 was found to have profound effects on transcription, it had no effect on replication of any minigenome tested, suggesting that it is not an active participant in RNA replication or regulation of RNA replication. Finally, since a permissive RSV infection is marked by a gradual increase in the intracellular accumulation of viral proteins including M2-1, we examined the relative abundances of various mRNAs during RSV infection for evidence of temporal regulation of transcription. None was found, implying that the availability of M2-1 during a permissive infection is sufficient at all times such that its concentration does not mediate temporal regulation of gene transcription.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364337      PMCID: PMC112646     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Sequential transcription of the genes of vesicular stomatitis virus.

Authors:  G Abraham; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  Nucleotide sequences of the 1B and 1C nonstructural protein mRNAs of human respiratory syncytial virus.

Authors:  P L Collins; G W Wertz
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

3.  cDNA cloning and transcriptional mapping of nine polyadenylylated RNAs encoded by the genome of human respiratory syncytial virus.

Authors:  P L Collins; G W Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

4.  Reconstitution studies detect a single polymerase entry site on the vesicular stomatitis virus genome.

Authors:  S U Emerson
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptides to the 10 viral genes.

Authors:  P L Collins; Y T Huang; G W Wertz
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

6.  Transcriptional mapping of human respiratory syncytial virus.

Authors:  L E Dickens; P L Collins; G W Wertz
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  Order of transcription of genes of vesicular stomatitis virus.

Authors:  L A Ball; C N White
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

8.  The genome of respiratory syncytial virus is a negative-stranded RNA that codes for at least seven mRNA species.

Authors:  Y T Huang; G W Wertz
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

9.  Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription.

Authors:  L E Iverson; J K Rose
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

10.  Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  105 in total

1.  Structural phosphoprotein M2-1 of the human respiratory syncytial virus is an RNA binding protein.

Authors:  I Cuesta; X Geng; A Asenjo; N Villanueva
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly.

Authors:  Anuradha Radhakrishnan; Dawn Yeo; Gaie Brown; Myint Zu Myaing; Laxmi Ravi Iyer; Roland Fleck; Boon-Huan Tan; Jim Aitken; Duangmanee Sanmun; Kai Tang; Andy Yarwood; Jacob Brink; Richard J Sugrue
Journal:  Mol Cell Proteomics       Date:  2010-06-08       Impact factor: 5.911

3.  Architecture and regulation of negative-strand viral enzymatic machinery.

Authors:  Philip J Kranzusch; Sean P J Whelan
Journal:  RNA Biol       Date:  2012-07-01       Impact factor: 4.652

4.  Ebolavirus polymerase uses an unconventional genome replication mechanism.

Authors:  Laure R Deflubé; Tessa N Cressey; Adam J Hume; Judith Olejnik; Elaine Haddock; Friederike Feldmann; Hideki Ebihara; Rachel Fearns; Elke Mühlberger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

5.  Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step.

Authors:  M E Peeples; P L Collins
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity.

Authors:  Stephen W Mason; Erika Aberg; Carol Lawetz; Rachel DeLong; Paul Whitehead; Michel Liuzzi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 8.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Biophysical and Dynamic Characterization of Fine-Tuned Binding of the Human Respiratory Syncytial Virus M2-1 Core Domain to Long RNAs.

Authors:  Icaro P Caruso; Giovana C Guimarães; Vitor B Machado; Marcelo A Fossey; Dieter Willbold; Fabio C L Almeida; Fátima P Souza
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

10.  Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA.

Authors:  Sander Herfst; Miranda de Graaf; Jeanne H Schickli; Roderick S Tang; Jasmine Kaur; Chin-Fen Yang; Richard R Spaete; Aurelia A Haller; Bernadette G van den Hoogen; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.